OLVIG
RNAM

Oliver Lagore Vanvalin Investment Group’s Avidity Biosciences RNAM Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$19.6K Buy
+663
New +$19.8K 0.01% 341
2024
Q4 		$19.3K Sell
663
-1,091
-62% -$45.6K ﹤0.01% 371
2024
Q3 		$80.6K Buy
1,754
+333
+23% +$14.5K 0.02% 195
2024
Q2 		$58K Hold
1,421
– – 0.02% 224
2024
Q1 		$36.3K Buy
+1,421
New +$22.3K 0.01% 269

Other funds holding RNAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's RNAM Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Avidity Biosciences (RNAM) in Q2 2025: 663 shares worth $19.6K. The stake represents 0.01% of the portfolio and ranks #341 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in RNAM as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in RNAM in Q1 2024 and has held it in 5 quarters since. The position peaked at $80.6K in Q3 2024. 206 funds tracked by Wall St. Rank hold RNAM as of Q2 2025.

  • Oliver Lagore Vanvalin Investment Group held 663 shares of Avidity Biosciences worth $19.6K as of Q2 2025.
  • Avidity Biosciences was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
  • Avidity Biosciences made up 0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #341 holding.
  • Oliver Lagore Vanvalin Investment Group first reported a position in Avidity Biosciences in Q1 2024 and has held it in 5 quarters since.
  • Oliver Lagore Vanvalin Investment Group's Avidity Biosciences position peaked at $80.6K in Q3 2024.
  • 206 funds tracked by Wall St. Rank held Avidity Biosciences as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.